Neuroprotective	O
Role	O
of	O
MicroRNA	B:C1537720
-	I:C1537720
22	I:C1537720
in	O
a	O
6	O
-	I:C0085196
Hydroxydopamine	I:C0085196
-	O
Induced	O
Cell	O
Model	O
of	O
Parkinson	O
's	I:C0030567
Disease	I:C0030567
via	O
Regulation	O
of	O
Its	O
Target	O
Gene	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
.	O

Neuroprotective	O
Role	O
of	O
MicroRNA	O
-	I:C1537720
22	I:C1537720
in	O
a	O
6	B:C0085196
-	I:C0085196
Hydroxydopamine	I:C0085196
-	O
Induced	O
Cell	O
Model	O
of	O
Parkinson	O
's	I:C0030567
Disease	I:C0030567
via	O
Regulation	O
of	O
Its	O
Target	O
Gene	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
.	O

Neuroprotective	O
Role	O
of	O
MicroRNA	O
-	I:C1537720
22	I:C1537720
in	O
a	O
6	O
-	I:C0085196
Hydroxydopamine	I:C0085196
-	O
Induced	O
Cell	B:C0007634
Model	O
of	O
Parkinson	O
's	I:C0030567
Disease	I:C0030567
via	O
Regulation	O
of	O
Its	O
Target	O
Gene	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
.	O

Neuroprotective	O
Role	O
of	O
MicroRNA	O
-	I:C1537720
22	I:C1537720
in	O
a	O
6	O
-	I:C0085196
Hydroxydopamine	I:C0085196
-	O
Induced	O
Cell	O
Model	B:C0684309
of	O
Parkinson	O
's	I:C0030567
Disease	I:C0030567
via	O
Regulation	O
of	O
Its	O
Target	O
Gene	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
.	O

Neuroprotective	O
Role	O
of	O
MicroRNA	O
-	I:C1537720
22	I:C1537720
in	O
a	O
6	O
-	I:C0085196
Hydroxydopamine	I:C0085196
-	O
Induced	O
Cell	O
Model	O
of	O
Parkinson	B:C0030567
's	I:C0030567
Disease	I:C0030567
via	O
Regulation	O
of	O
Its	O
Target	O
Gene	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
.	O

Neuroprotective	O
Role	O
of	O
MicroRNA	O
-	I:C1537720
22	I:C1537720
in	O
a	O
6	O
-	I:C0085196
Hydroxydopamine	I:C0085196
-	O
Induced	O
Cell	O
Model	O
of	O
Parkinson	O
's	I:C0030567
Disease	I:C0030567
via	O
Regulation	B:C0017263
of	O
Its	O
Target	O
Gene	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
.	O

Neuroprotective	O
Role	O
of	O
MicroRNA	O
-	I:C1537720
22	I:C1537720
in	O
a	O
6	O
-	I:C0085196
Hydroxydopamine	I:C0085196
-	O
Induced	O
Cell	O
Model	O
of	O
Parkinson	O
's	I:C0030567
Disease	I:C0030567
via	O
Regulation	O
of	O
Its	O
Target	O
Gene	B:C0017337
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
.	O

Neuroprotective	O
Role	O
of	O
MicroRNA	O
-	I:C1537720
22	I:C1537720
in	O
a	O
6	O
-	I:C0085196
Hydroxydopamine	I:C0085196
-	O
Induced	O
Cell	O
Model	O
of	O
Parkinson	O
's	I:C0030567
Disease	I:C0030567
via	O
Regulation	O
of	O
Its	O
Target	O
Gene	O
transient	B:C1425224
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
.	O

Parkinson	B:C0030567
's	I:C0030567
disease	I:C0030567
(	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
)	O
,	O
the	O
second	O
most	O
prevalent	O
neurodegenerative	O
disorder	I:C0524851
with	O
only	O
symptomatic	O
treatment	O
available	O
,	O
is	O
characterized	O
by	O
a	O
progressive	O
loss	O
of	O
dopaminergic	O
neurons	I:C1512035
in	O
the	O
midbrain	O
.	O

Parkinson	O
's	I:C0030567
disease	I:C0030567
(	O
Parkinson	B:C0030567
's	I:C0030567
disease	I:C0030567
)	O
,	O
the	O
second	O
most	O
prevalent	O
neurodegenerative	O
disorder	I:C0524851
with	O
only	O
symptomatic	O
treatment	O
available	O
,	O
is	O
characterized	O
by	O
a	O
progressive	O
loss	O
of	O
dopaminergic	O
neurons	I:C1512035
in	O
the	O
midbrain	O
.	O

Parkinson	O
's	I:C0030567
disease	I:C0030567
(	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
)	O
,	O
the	O
second	O
most	O
prevalent	B:C0205391
neurodegenerative	O
disorder	I:C0524851
with	O
only	O
symptomatic	O
treatment	O
available	O
,	O
is	O
characterized	O
by	O
a	O
progressive	O
loss	O
of	O
dopaminergic	O
neurons	I:C1512035
in	O
the	O
midbrain	O
.	O

Parkinson	O
's	I:C0030567
disease	I:C0030567
(	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
)	O
,	O
the	O
second	O
most	O
prevalent	O
neurodegenerative	B:C0524851
disorder	I:C0524851
with	O
only	O
symptomatic	O
treatment	O
available	O
,	O
is	O
characterized	O
by	O
a	O
progressive	O
loss	O
of	O
dopaminergic	O
neurons	I:C1512035
in	O
the	O
midbrain	O
.	O

Parkinson	O
's	I:C0030567
disease	I:C0030567
(	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
)	O
,	O
the	O
second	O
most	O
prevalent	O
neurodegenerative	O
disorder	I:C0524851
with	O
only	O
symptomatic	O
treatment	B:C0087111
available	O
,	O
is	O
characterized	O
by	O
a	O
progressive	O
loss	O
of	O
dopaminergic	O
neurons	I:C1512035
in	O
the	O
midbrain	O
.	O

Parkinson	O
's	I:C0030567
disease	I:C0030567
(	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
)	O
,	O
the	O
second	O
most	O
prevalent	O
neurodegenerative	O
disorder	I:C0524851
with	O
only	O
symptomatic	O
treatment	O
available	O
,	O
is	O
characterized	O
by	O
a	O
progressive	O
loss	O
of	O
dopaminergic	B:C1512035
neurons	I:C1512035
in	O
the	O
midbrain	O
.	O

Parkinson	O
's	I:C0030567
disease	I:C0030567
(	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
)	O
,	O
the	O
second	O
most	O
prevalent	O
neurodegenerative	O
disorder	I:C0524851
with	O
only	O
symptomatic	O
treatment	O
available	O
,	O
is	O
characterized	O
by	O
a	O
progressive	O
loss	O
of	O
dopaminergic	O
neurons	I:C1512035
in	O
the	O
midbrain	B:C0025462
.	O

Ample	O
evidence	O
indicated	O
that	O
microRNAs	B:C1101610
(	O
microRNAs	O
)	O
could	O
regulate	O
post	I:C1514248
-	I:C1514248
transcriptional	I:C1514248
gene	O
expression	I:C0017262
and	O
neuronal	O
disease	I:C0027765
.	O

Ample	O
evidence	O
indicated	O
that	O
microRNAs	O
(	O
microRNAs	B:C1101610
)	O
could	O
regulate	O
post	I:C1514248
-	I:C1514248
transcriptional	I:C1514248
gene	O
expression	I:C0017262
and	O
neuronal	O
disease	I:C0027765
.	O

Ample	O
evidence	O
indicated	O
that	O
microRNAs	O
(	O
microRNAs	O
)	O
could	O
regulate	B:C1514248
post	I:C1514248
-	I:C1514248
transcriptional	I:C1514248
gene	O
expression	I:C0017262
and	O
neuronal	O
disease	I:C0027765
.	O

Ample	O
evidence	O
indicated	O
that	O
microRNAs	O
(	O
microRNAs	O
)	O
could	O
regulate	O
post	I:C1514248
-	I:C1514248
transcriptional	I:C1514248
gene	B:C0017262
expression	I:C0017262
and	O
neuronal	O
disease	I:C0027765
.	O

Ample	O
evidence	O
indicated	O
that	O
microRNAs	O
(	O
microRNAs	O
)	O
could	O
regulate	O
post	I:C1514248
-	I:C1514248
transcriptional	I:C1514248
gene	O
expression	I:C0017262
and	O
neuronal	B:C0027765
disease	I:C0027765
.	O

In	O
the	O
present	O
study	B:C2603343
,	O
we	O
have	O
evaluated	O
the	O
effects	O
and	O
mechanism	O
of	O
miR	O
-	I:C1537720
22	I:C1537720
in	O
PC12	O
pheochromocytoma	I:C0085262
cells	I:C0085262
treated	O
with	O
6	O
-	I:C0085196
hydroxydopamine	I:C0085196
(	O
6	O
-	I:C0085196
OHDA	I:C0085196
)	O
to	O
mimic	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
.	O

In	O
the	O
present	O
study	O
,	O
we	O
have	O
evaluated	O
the	O
effects	O
and	O
mechanism	O
of	O
miR	B:C1537720
-	I:C1537720
22	I:C1537720
in	O
PC12	O
pheochromocytoma	I:C0085262
cells	I:C0085262
treated	O
with	O
6	O
-	I:C0085196
hydroxydopamine	I:C0085196
(	O
6	O
-	I:C0085196
OHDA	I:C0085196
)	O
to	O
mimic	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
.	O

In	O
the	O
present	O
study	O
,	O
we	O
have	O
evaluated	O
the	O
effects	O
and	O
mechanism	O
of	O
miR	O
-	I:C1537720
22	I:C1537720
in	O
PC12	B:C0085262
pheochromocytoma	I:C0085262
cells	I:C0085262
treated	O
with	O
6	O
-	I:C0085196
hydroxydopamine	I:C0085196
(	O
6	O
-	I:C0085196
OHDA	I:C0085196
)	O
to	O
mimic	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
.	O

In	O
the	O
present	O
study	O
,	O
we	O
have	O
evaluated	O
the	O
effects	O
and	O
mechanism	O
of	O
miR	O
-	I:C1537720
22	I:C1537720
in	O
PC12	O
pheochromocytoma	I:C0085262
cells	I:C0085262
treated	O
with	O
6	B:C0085196
-	I:C0085196
hydroxydopamine	I:C0085196
(	O
6	O
-	I:C0085196
OHDA	I:C0085196
)	O
to	O
mimic	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
.	O

In	O
the	O
present	O
study	O
,	O
we	O
have	O
evaluated	O
the	O
effects	O
and	O
mechanism	O
of	O
miR	O
-	I:C1537720
22	I:C1537720
in	O
PC12	O
pheochromocytoma	I:C0085262
cells	I:C0085262
treated	O
with	O
6	O
-	I:C0085196
hydroxydopamine	I:C0085196
(	O
6	B:C0085196
-	I:C0085196
OHDA	I:C0085196
)	O
to	O
mimic	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
.	O

In	O
the	O
present	O
study	O
,	O
we	O
have	O
evaluated	O
the	O
effects	O
and	O
mechanism	O
of	O
miR	O
-	I:C1537720
22	I:C1537720
in	O
PC12	O
pheochromocytoma	I:C0085262
cells	I:C0085262
treated	O
with	O
6	O
-	I:C0085196
hydroxydopamine	I:C0085196
(	O
6	O
-	I:C0085196
OHDA	I:C0085196
)	O
to	O
mimic	O
Parkinson	B:C0030567
's	I:C0030567
disease	I:C0030567
.	O

RT	B:C0599161
-	I:C0599161
PCR	I:C0599161
results	O
showed	O
that	O
the	O
expression	O
of	O
miR	O
-	I:C1537720
22	I:C1537720
is	O
downregulated	O
in	O
6	O
-	I:C0085196
OHDA	I:C0085196
-	O
treated	O
PC12	O
cells	I:C0085262
,	O
and	O
the	O
overexpression	O
of	O
miR	O
-	I:C1537720
22	I:C1537720
significantly	O
promoted	O
the	O
survival	O
and	O
proliferation	O
of	O
6	O
-	I:C0085196
OHDA	I:C0085196
-	O
induced	O
PC12	O
cells	I:C0085262
,	O
whereas	O
miR	O
-	I:C1537720
22	I:C1537720
inhibitor	O
reversed	O
these	O
effects	O
.	O

RT	O
-	I:C0599161
PCR	I:C0599161
results	O
showed	O
that	O
the	O
expression	B:C0017262
of	O
miR	O
-	I:C1537720
22	I:C1537720
is	O
downregulated	O
in	O
6	O
-	I:C0085196
OHDA	I:C0085196
-	O
treated	O
PC12	O
cells	I:C0085262
,	O
and	O
the	O
overexpression	O
of	O
miR	O
-	I:C1537720
22	I:C1537720
significantly	O
promoted	O
the	O
survival	O
and	O
proliferation	O
of	O
6	O
-	I:C0085196
OHDA	I:C0085196
-	O
induced	O
PC12	O
cells	I:C0085262
,	O
whereas	O
miR	O
-	I:C1537720
22	I:C1537720
inhibitor	O
reversed	O
these	O
effects	O
.	O

RT	O
-	I:C0599161
PCR	I:C0599161
results	O
showed	O
that	O
the	O
expression	O
of	O
miR	B:C1537720
-	I:C1537720
22	I:C1537720
is	O
downregulated	O
in	O
6	O
-	I:C0085196
OHDA	I:C0085196
-	O
treated	O
PC12	O
cells	I:C0085262
,	O
and	O
the	O
overexpression	O
of	O
miR	O
-	I:C1537720
22	I:C1537720
significantly	O
promoted	O
the	O
survival	O
and	O
proliferation	O
of	O
6	O
-	I:C0085196
OHDA	I:C0085196
-	O
induced	O
PC12	O
cells	I:C0085262
,	O
whereas	O
miR	O
-	I:C1537720
22	I:C1537720
inhibitor	O
reversed	O
these	O
effects	O
.	O

RT	O
-	I:C0599161
PCR	I:C0599161
results	O
showed	O
that	O
the	O
expression	O
of	O
miR	O
-	I:C1537720
22	I:C1537720
is	O
downregulated	B:C0013081
in	O
6	O
-	I:C0085196
OHDA	I:C0085196
-	O
treated	O
PC12	O
cells	I:C0085262
,	O
and	O
the	O
overexpression	O
of	O
miR	O
-	I:C1537720
22	I:C1537720
significantly	O
promoted	O
the	O
survival	O
and	O
proliferation	O
of	O
6	O
-	I:C0085196
OHDA	I:C0085196
-	O
induced	O
PC12	O
cells	I:C0085262
,	O
whereas	O
miR	O
-	I:C1537720
22	I:C1537720
inhibitor	O
reversed	O
these	O
effects	O
.	O

RT	O
-	I:C0599161
PCR	I:C0599161
results	O
showed	O
that	O
the	O
expression	O
of	O
miR	O
-	I:C1537720
22	I:C1537720
is	O
downregulated	O
in	O
6	B:C0085196
-	I:C0085196
OHDA	I:C0085196
-	O
treated	O
PC12	O
cells	I:C0085262
,	O
and	O
the	O
overexpression	O
of	O
miR	O
-	I:C1537720
22	I:C1537720
significantly	O
promoted	O
the	O
survival	O
and	O
proliferation	O
of	O
6	O
-	I:C0085196
OHDA	I:C0085196
-	O
induced	O
PC12	O
cells	I:C0085262
,	O
whereas	O
miR	O
-	I:C1537720
22	I:C1537720
inhibitor	O
reversed	O
these	O
effects	O
.	O

RT	O
-	I:C0599161
PCR	I:C0599161
results	O
showed	O
that	O
the	O
expression	O
of	O
miR	O
-	I:C1537720
22	I:C1537720
is	O
downregulated	O
in	O
6	O
-	I:C0085196
OHDA	I:C0085196
-	O
treated	O
PC12	B:C0085262
cells	I:C0085262
,	O
and	O
the	O
overexpression	O
of	O
miR	O
-	I:C1537720
22	I:C1537720
significantly	O
promoted	O
the	O
survival	O
and	O
proliferation	O
of	O
6	O
-	I:C0085196
OHDA	I:C0085196
-	O
induced	O
PC12	O
cells	I:C0085262
,	O
whereas	O
miR	O
-	I:C1537720
22	I:C1537720
inhibitor	O
reversed	O
these	O
effects	O
.	O

RT	O
-	I:C0599161
PCR	I:C0599161
results	O
showed	O
that	O
the	O
expression	O
of	O
miR	O
-	I:C1537720
22	I:C1537720
is	O
downregulated	O
in	O
6	O
-	I:C0085196
OHDA	I:C0085196
-	O
treated	O
PC12	O
cells	I:C0085262
,	O
and	O
the	O
overexpression	B:C0017262
of	O
miR	O
-	I:C1537720
22	I:C1537720
significantly	O
promoted	O
the	O
survival	O
and	O
proliferation	O
of	O
6	O
-	I:C0085196
OHDA	I:C0085196
-	O
induced	O
PC12	O
cells	I:C0085262
,	O
whereas	O
miR	O
-	I:C1537720
22	I:C1537720
inhibitor	O
reversed	O
these	O
effects	O
.	O

RT	O
-	I:C0599161
PCR	I:C0599161
results	O
showed	O
that	O
the	O
expression	O
of	O
miR	O
-	I:C1537720
22	I:C1537720
is	O
downregulated	O
in	O
6	O
-	I:C0085196
OHDA	I:C0085196
-	O
treated	O
PC12	O
cells	I:C0085262
,	O
and	O
the	O
overexpression	O
of	O
miR	B:C1537720
-	I:C1537720
22	I:C1537720
significantly	O
promoted	O
the	O
survival	O
and	O
proliferation	O
of	O
6	O
-	I:C0085196
OHDA	I:C0085196
-	O
induced	O
PC12	O
cells	I:C0085262
,	O
whereas	O
miR	O
-	I:C1537720
22	I:C1537720
inhibitor	O
reversed	O
these	O
effects	O
.	O

RT	O
-	I:C0599161
PCR	I:C0599161
results	O
showed	O
that	O
the	O
expression	O
of	O
miR	O
-	I:C1537720
22	I:C1537720
is	O
downregulated	O
in	O
6	O
-	I:C0085196
OHDA	I:C0085196
-	O
treated	O
PC12	O
cells	I:C0085262
,	O
and	O
the	O
overexpression	O
of	O
miR	O
-	I:C1537720
22	I:C1537720
significantly	O
promoted	O
the	O
survival	B:C0007620
and	O
proliferation	O
of	O
6	O
-	I:C0085196
OHDA	I:C0085196
-	O
induced	O
PC12	O
cells	I:C0085262
,	O
whereas	O
miR	O
-	I:C1537720
22	I:C1537720
inhibitor	O
reversed	O
these	O
effects	O
.	O

RT	O
-	I:C0599161
PCR	I:C0599161
results	O
showed	O
that	O
the	O
expression	O
of	O
miR	O
-	I:C1537720
22	I:C1537720
is	O
downregulated	O
in	O
6	O
-	I:C0085196
OHDA	I:C0085196
-	O
treated	O
PC12	O
cells	I:C0085262
,	O
and	O
the	O
overexpression	O
of	O
miR	O
-	I:C1537720
22	I:C1537720
significantly	O
promoted	O
the	O
survival	O
and	O
proliferation	B:C0596290
of	O
6	O
-	I:C0085196
OHDA	I:C0085196
-	O
induced	O
PC12	O
cells	I:C0085262
,	O
whereas	O
miR	O
-	I:C1537720
22	I:C1537720
inhibitor	O
reversed	O
these	O
effects	O
.	O

RT	O
-	I:C0599161
PCR	I:C0599161
results	O
showed	O
that	O
the	O
expression	O
of	O
miR	O
-	I:C1537720
22	I:C1537720
is	O
downregulated	O
in	O
6	O
-	I:C0085196
OHDA	I:C0085196
-	O
treated	O
PC12	O
cells	I:C0085262
,	O
and	O
the	O
overexpression	O
of	O
miR	O
-	I:C1537720
22	I:C1537720
significantly	O
promoted	O
the	O
survival	O
and	O
proliferation	O
of	O
6	B:C0085196
-	I:C0085196
OHDA	I:C0085196
-	O
induced	O
PC12	O
cells	I:C0085262
,	O
whereas	O
miR	O
-	I:C1537720
22	I:C1537720
inhibitor	O
reversed	O
these	O
effects	O
.	O

RT	O
-	I:C0599161
PCR	I:C0599161
results	O
showed	O
that	O
the	O
expression	O
of	O
miR	O
-	I:C1537720
22	I:C1537720
is	O
downregulated	O
in	O
6	O
-	I:C0085196
OHDA	I:C0085196
-	O
treated	O
PC12	O
cells	I:C0085262
,	O
and	O
the	O
overexpression	O
of	O
miR	O
-	I:C1537720
22	I:C1537720
significantly	O
promoted	O
the	O
survival	O
and	O
proliferation	O
of	O
6	O
-	I:C0085196
OHDA	I:C0085196
-	O
induced	O
PC12	B:C0085262
cells	I:C0085262
,	O
whereas	O
miR	O
-	I:C1537720
22	I:C1537720
inhibitor	O
reversed	O
these	O
effects	O
.	O

RT	O
-	I:C0599161
PCR	I:C0599161
results	O
showed	O
that	O
the	O
expression	O
of	O
miR	O
-	I:C1537720
22	I:C1537720
is	O
downregulated	O
in	O
6	O
-	I:C0085196
OHDA	I:C0085196
-	O
treated	O
PC12	O
cells	I:C0085262
,	O
and	O
the	O
overexpression	O
of	O
miR	O
-	I:C1537720
22	I:C1537720
significantly	O
promoted	O
the	O
survival	O
and	O
proliferation	O
of	O
6	O
-	I:C0085196
OHDA	I:C0085196
-	O
induced	O
PC12	O
cells	I:C0085262
,	O
whereas	O
miR	B:C1537720
-	I:C1537720
22	I:C1537720
inhibitor	O
reversed	O
these	O
effects	O
.	O

In	O
addition	O
,	O
PC12	B:C0085262
cells	I:C0085262
were	O
treated	O
with	O
miR	O
-	I:C1537720
22	I:C1537720
mimics	I:C1537720
or	O
inhibitor	O
following	O
6	O
-	I:C0085196
OHDA	I:C0085196
administration	O
,	O
which	O
medicated	O
ROS	O
production	O
and	O
upregulation	O
or	O
downregulation	O
of	O
caspase	O
-	I:C1150132
3	I:C1150132
activity	I:C1150132
,	O
respectively	O
.	O

In	O
addition	O
,	O
PC12	O
cells	I:C0085262
were	O
treated	O
with	O
miR	B:C1537720
-	I:C1537720
22	I:C1537720
mimics	I:C1537720
or	O
inhibitor	O
following	O
6	O
-	I:C0085196
OHDA	I:C0085196
administration	O
,	O
which	O
medicated	O
ROS	O
production	O
and	O
upregulation	O
or	O
downregulation	O
of	O
caspase	O
-	I:C1150132
3	I:C1150132
activity	I:C1150132
,	O
respectively	O
.	O

In	O
addition	O
,	O
PC12	O
cells	I:C0085262
were	O
treated	O
with	O
miR	O
-	I:C1537720
22	I:C1537720
mimics	I:C1537720
or	O
inhibitor	O
following	O
6	B:C0085196
-	I:C0085196
OHDA	I:C0085196
administration	O
,	O
which	O
medicated	O
ROS	O
production	O
and	O
upregulation	O
or	O
downregulation	O
of	O
caspase	O
-	I:C1150132
3	I:C1150132
activity	I:C1150132
,	O
respectively	O
.	O

In	O
addition	O
,	O
PC12	O
cells	I:C0085262
were	O
treated	O
with	O
miR	O
-	I:C1537720
22	I:C1537720
mimics	I:C1537720
or	O
inhibitor	O
following	O
6	O
-	I:C0085196
OHDA	I:C0085196
administration	B:C1533734
,	O
which	O
medicated	O
ROS	O
production	O
and	O
upregulation	O
or	O
downregulation	O
of	O
caspase	O
-	I:C1150132
3	I:C1150132
activity	I:C1150132
,	O
respectively	O
.	O

In	O
addition	O
,	O
PC12	O
cells	I:C0085262
were	O
treated	O
with	O
miR	O
-	I:C1537720
22	I:C1537720
mimics	I:C1537720
or	O
inhibitor	O
following	O
6	O
-	I:C0085196
OHDA	I:C0085196
administration	O
,	O
which	O
medicated	O
ROS	B:C0162772
production	O
and	O
upregulation	O
or	O
downregulation	O
of	O
caspase	O
-	I:C1150132
3	I:C1150132
activity	I:C1150132
,	O
respectively	O
.	O

In	O
addition	O
,	O
PC12	O
cells	I:C0085262
were	O
treated	O
with	O
miR	O
-	I:C1537720
22	I:C1537720
mimics	I:C1537720
or	O
inhibitor	O
following	O
6	O
-	I:C0085196
OHDA	I:C0085196
administration	O
,	O
which	O
medicated	O
ROS	O
production	B:C1148560
and	O
upregulation	O
or	O
downregulation	O
of	O
caspase	O
-	I:C1150132
3	I:C1150132
activity	I:C1150132
,	O
respectively	O
.	O

In	O
addition	O
,	O
PC12	O
cells	I:C0085262
were	O
treated	O
with	O
miR	O
-	I:C1537720
22	I:C1537720
mimics	I:C1537720
or	O
inhibitor	O
following	O
6	O
-	I:C0085196
OHDA	I:C0085196
administration	O
,	O
which	O
medicated	O
ROS	O
production	O
and	O
upregulation	B:C0041904
or	O
downregulation	O
of	O
caspase	O
-	I:C1150132
3	I:C1150132
activity	I:C1150132
,	O
respectively	O
.	O

In	O
addition	O
,	O
PC12	O
cells	I:C0085262
were	O
treated	O
with	O
miR	O
-	I:C1537720
22	I:C1537720
mimics	I:C1537720
or	O
inhibitor	O
following	O
6	O
-	I:C0085196
OHDA	I:C0085196
administration	O
,	O
which	O
medicated	O
ROS	O
production	O
and	O
upregulation	O
or	O
downregulation	B:C0013081
of	O
caspase	O
-	I:C1150132
3	I:C1150132
activity	I:C1150132
,	O
respectively	O
.	O

In	O
addition	O
,	O
PC12	O
cells	I:C0085262
were	O
treated	O
with	O
miR	O
-	I:C1537720
22	I:C1537720
mimics	I:C1537720
or	O
inhibitor	O
following	O
6	O
-	I:C0085196
OHDA	I:C0085196
administration	O
,	O
which	O
medicated	O
ROS	O
production	O
and	O
upregulation	O
or	O
downregulation	O
of	O
caspase	B:C1150132
-	I:C1150132
3	I:C1150132
activity	I:C1150132
,	O
respectively	O
.	O

A	O
luciferase	B:C0024075
reporter	O
assay	O
revealed	O
that	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
(	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
)	O
is	O
a	O
direct	O
target	O
gene	O
of	O
miR	O
-	I:C1537720
22	I:C1537720
,	O
and	O
miR	O
-	I:C1537720
22	I:C1537720
overexpression	O
markedly	O
downregulated	O
the	O
level	O
of	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
.	O

A	O
luciferase	O
reporter	O
assay	B:C2717977
revealed	O
that	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
(	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
)	O
is	O
a	O
direct	O
target	O
gene	O
of	O
miR	O
-	I:C1537720
22	I:C1537720
,	O
and	O
miR	O
-	I:C1537720
22	I:C1537720
overexpression	O
markedly	O
downregulated	O
the	O
level	O
of	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
.	O

A	O
luciferase	O
reporter	O
assay	O
revealed	O
that	O
transient	B:C1425224
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
(	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
)	O
is	O
a	O
direct	O
target	O
gene	O
of	O
miR	O
-	I:C1537720
22	I:C1537720
,	O
and	O
miR	O
-	I:C1537720
22	I:C1537720
overexpression	O
markedly	O
downregulated	O
the	O
level	O
of	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
.	O

A	O
luciferase	O
reporter	O
assay	O
revealed	O
that	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
(	O
transient	B:C1425224
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
)	O
is	O
a	O
direct	O
target	O
gene	O
of	O
miR	O
-	I:C1537720
22	I:C1537720
,	O
and	O
miR	O
-	I:C1537720
22	I:C1537720
overexpression	O
markedly	O
downregulated	O
the	O
level	O
of	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
.	O

A	O
luciferase	O
reporter	O
assay	O
revealed	O
that	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
(	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
)	O
is	O
a	O
direct	O
target	O
gene	B:C0017337
of	O
miR	O
-	I:C1537720
22	I:C1537720
,	O
and	O
miR	O
-	I:C1537720
22	I:C1537720
overexpression	O
markedly	O
downregulated	O
the	O
level	O
of	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
.	O

A	O
luciferase	O
reporter	O
assay	O
revealed	O
that	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
(	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
)	O
is	O
a	O
direct	O
target	O
gene	O
of	O
miR	B:C1537720
-	I:C1537720
22	I:C1537720
,	O
and	O
miR	O
-	I:C1537720
22	I:C1537720
overexpression	O
markedly	O
downregulated	O
the	O
level	O
of	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
.	O

A	O
luciferase	O
reporter	O
assay	O
revealed	O
that	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
(	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
)	O
is	O
a	O
direct	O
target	O
gene	O
of	O
miR	O
-	I:C1537720
22	I:C1537720
,	O
and	O
miR	B:C1537720
-	I:C1537720
22	I:C1537720
overexpression	O
markedly	O
downregulated	O
the	O
level	O
of	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
.	O

A	O
luciferase	O
reporter	O
assay	O
revealed	O
that	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
(	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
)	O
is	O
a	O
direct	O
target	O
gene	O
of	O
miR	O
-	I:C1537720
22	I:C1537720
,	O
and	O
miR	O
-	I:C1537720
22	I:C1537720
overexpression	B:C0017262
markedly	O
downregulated	O
the	O
level	O
of	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
.	O

A	O
luciferase	O
reporter	O
assay	O
revealed	O
that	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
(	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
)	O
is	O
a	O
direct	O
target	O
gene	O
of	O
miR	O
-	I:C1537720
22	I:C1537720
,	O
and	O
miR	O
-	I:C1537720
22	I:C1537720
overexpression	O
markedly	O
downregulated	B:C0013081
the	O
level	O
of	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
.	O

A	O
luciferase	O
reporter	O
assay	O
revealed	O
that	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
(	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
)	O
is	O
a	O
direct	O
target	O
gene	O
of	O
miR	O
-	I:C1537720
22	I:C1537720
,	O
and	O
miR	O
-	I:C1537720
22	I:C1537720
overexpression	O
markedly	O
downregulated	O
the	O
level	O
of	O
transient	B:C1425224
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
.	O

Strikingly	O
,	O
further	O
analysis	B:C0936012
showed	O
that	O
miR	O
-	I:C1537720
22	I:C1537720
mediated	O
6	O
-	I:C0085196
OHDA	I:C0085196
-	O
induced	O
PC12	O
cell	O
survival	I:C0007620
and	O
proliferation	O
by	O
targeting	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
.	O

Strikingly	O
,	O
further	O
analysis	O
showed	O
that	O
miR	B:C1537720
-	I:C1537720
22	I:C1537720
mediated	O
6	O
-	I:C0085196
OHDA	I:C0085196
-	O
induced	O
PC12	O
cell	O
survival	I:C0007620
and	O
proliferation	O
by	O
targeting	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
.	O

Strikingly	O
,	O
further	O
analysis	O
showed	O
that	O
miR	O
-	I:C1537720
22	I:C1537720
mediated	O
6	B:C0085196
-	I:C0085196
OHDA	I:C0085196
-	O
induced	O
PC12	O
cell	O
survival	I:C0007620
and	O
proliferation	O
by	O
targeting	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
.	O

Strikingly	O
,	O
further	O
analysis	O
showed	O
that	O
miR	O
-	I:C1537720
22	I:C1537720
mediated	O
6	O
-	I:C0085196
OHDA	I:C0085196
-	O
induced	O
PC12	B:C0085262
cell	O
survival	I:C0007620
and	O
proliferation	O
by	O
targeting	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
.	O

Strikingly	O
,	O
further	O
analysis	O
showed	O
that	O
miR	O
-	I:C1537720
22	I:C1537720
mediated	O
6	O
-	I:C0085196
OHDA	I:C0085196
-	O
induced	O
PC12	O
cell	B:C0007620
survival	I:C0007620
and	O
proliferation	O
by	O
targeting	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
.	O

Strikingly	O
,	O
further	O
analysis	O
showed	O
that	O
miR	O
-	I:C1537720
22	I:C1537720
mediated	O
6	O
-	I:C0085196
OHDA	I:C0085196
-	O
induced	O
PC12	O
cell	O
survival	I:C0007620
and	O
proliferation	B:C0596290
by	O
targeting	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
.	O

Strikingly	O
,	O
further	O
analysis	O
showed	O
that	O
miR	O
-	I:C1537720
22	I:C1537720
mediated	O
6	O
-	I:C0085196
OHDA	I:C0085196
-	O
induced	O
PC12	O
cell	O
survival	I:C0007620
and	O
proliferation	O
by	O
targeting	O
transient	B:C1425224
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
.	O

Taken	O
together	O
,	O
the	O
present	O
study	B:C2603343
showed	O
that	O
miR	O
-	I:C1537720
22	I:C1537720
overexpression	O
exhibited	O
neuroprotective	O
and	O
reversal	O
effects	O
on	O
the	O
6	O
-	I:C0085196
OHDA	I:C0085196
-	O
induced	O
PC12	O
cell	O
growth	I:C0007595
and	O
apoptosis	O
by	O
targeting	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
.	O

Taken	O
together	O
,	O
the	O
present	O
study	O
showed	O
that	O
miR	B:C1537720
-	I:C1537720
22	I:C1537720
overexpression	O
exhibited	O
neuroprotective	O
and	O
reversal	O
effects	O
on	O
the	O
6	O
-	I:C0085196
OHDA	I:C0085196
-	O
induced	O
PC12	O
cell	O
growth	I:C0007595
and	O
apoptosis	O
by	O
targeting	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
.	O

Taken	O
together	O
,	O
the	O
present	O
study	O
showed	O
that	O
miR	O
-	I:C1537720
22	I:C1537720
overexpression	B:C0017262
exhibited	O
neuroprotective	O
and	O
reversal	O
effects	O
on	O
the	O
6	O
-	I:C0085196
OHDA	I:C0085196
-	O
induced	O
PC12	O
cell	O
growth	I:C0007595
and	O
apoptosis	O
by	O
targeting	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
.	O

Taken	O
together	O
,	O
the	O
present	O
study	O
showed	O
that	O
miR	O
-	I:C1537720
22	I:C1537720
overexpression	O
exhibited	O
neuroprotective	O
and	O
reversal	O
effects	O
on	O
the	O
6	B:C0085196
-	I:C0085196
OHDA	I:C0085196
-	O
induced	O
PC12	O
cell	O
growth	I:C0007595
and	O
apoptosis	O
by	O
targeting	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
.	O

Taken	O
together	O
,	O
the	O
present	O
study	O
showed	O
that	O
miR	O
-	I:C1537720
22	I:C1537720
overexpression	O
exhibited	O
neuroprotective	O
and	O
reversal	O
effects	O
on	O
the	O
6	O
-	I:C0085196
OHDA	I:C0085196
-	O
induced	O
PC12	B:C0085262
cell	O
growth	I:C0007595
and	O
apoptosis	O
by	O
targeting	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
.	O

Taken	O
together	O
,	O
the	O
present	O
study	O
showed	O
that	O
miR	O
-	I:C1537720
22	I:C1537720
overexpression	O
exhibited	O
neuroprotective	O
and	O
reversal	O
effects	O
on	O
the	O
6	O
-	I:C0085196
OHDA	I:C0085196
-	O
induced	O
PC12	O
cell	B:C0007595
growth	I:C0007595
and	O
apoptosis	O
by	O
targeting	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
.	O

Taken	O
together	O
,	O
the	O
present	O
study	O
showed	O
that	O
miR	O
-	I:C1537720
22	I:C1537720
overexpression	O
exhibited	O
neuroprotective	O
and	O
reversal	O
effects	O
on	O
the	O
6	O
-	I:C0085196
OHDA	I:C0085196
-	O
induced	O
PC12	O
cell	O
growth	I:C0007595
and	O
apoptosis	B:C0162638
by	O
targeting	O
transient	O
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
.	O

Taken	O
together	O
,	O
the	O
present	O
study	O
showed	O
that	O
miR	O
-	I:C1537720
22	I:C1537720
overexpression	O
exhibited	O
neuroprotective	O
and	O
reversal	O
effects	O
on	O
the	O
6	O
-	I:C0085196
OHDA	I:C0085196
-	O
induced	O
PC12	O
cell	O
growth	I:C0007595
and	O
apoptosis	O
by	O
targeting	O
transient	B:C1425224
receptor	I:C1425224
potential	I:C1425224
melastatin	I:C1425224
7	I:C1425224
.	O

